210 related articles for article (PubMed ID: 33864598)
1. Sex Differences in Glioblastoma Immunotherapy Response.
Lee J; Kay K; Troike K; Ahluwalia MS; Lathia JD
Neuromolecular Med; 2022 Mar; 24(1):50-55. PubMed ID: 33864598
[TBL] [Abstract][Full Text] [Related]
2. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
3. Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.
Lee J; Troike K; Fodor R; Lathia JD
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35023543
[TBL] [Abstract][Full Text] [Related]
4. New Directions in the Treatment of Glioblastoma.
Reitman ZJ; Winkler F; Elia AEH
Semin Neurol; 2018 Feb; 38(1):50-61. PubMed ID: 29548052
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma Immune Landscape and the Potential of New Immunotherapies.
Daubon T; Hemadou A; Romero Garmendia I; Saleh M
Front Immunol; 2020; 11():585616. PubMed ID: 33154756
[TBL] [Abstract][Full Text] [Related]
6. Immunological Aspects of Malignant Gliomas.
Cohen-Inbar O; Zaaroor M
Can J Neurol Sci; 2016 Jul; 43(4):494-502. PubMed ID: 27324313
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of immunotherapy resistance: lessons from glioblastoma.
Jackson CM; Choi J; Lim M
Nat Immunol; 2019 Sep; 20(9):1100-1109. PubMed ID: 31358997
[TBL] [Abstract][Full Text] [Related]
8. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
9. The Safety of available immunotherapy for the treatment of glioblastoma.
Farber SH; Elsamadicy AA; Atik AF; Suryadevara CM; Chongsathidkiet P; Fecci PE; Sampson JH
Expert Opin Drug Saf; 2017 Mar; 16(3):277-287. PubMed ID: 27989218
[TBL] [Abstract][Full Text] [Related]
10. Sex-Specific Differences in Glioblastoma.
Carrano A; Juarez JJ; Incontri D; Ibarra A; Guerrero Cazares H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359952
[TBL] [Abstract][Full Text] [Related]
11. Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.
Lee J; Nicosia M; Hong ES; Silver DJ; Li C; Bayik D; Watson DC; Lauko A; Kay KE; Wang SZ; Johnson S; McGraw M; Grabowski MM; Kish DD; Desai AB; Goodman WA; Cameron SJ; Okada H; Valujskikh A; Fairchild RL; Ahluwalia MS; Lathia JD
Cancer Discov; 2023 Sep; 13(9):2090-2105. PubMed ID: 37378557
[TBL] [Abstract][Full Text] [Related]
12. Contemporary RNA Therapeutics for Glioblastoma.
Melnick K; Dastmalchi F; Mitchell D; Rahman M; Sayour EJ
Neuromolecular Med; 2022 Mar; 24(1):8-12. PubMed ID: 34101090
[TBL] [Abstract][Full Text] [Related]
13. Using viral vectors to deliver local immunotherapy to glioblastoma.
Haddad AF; Young JS; Aghi MK
Neurosurg Focus; 2021 Feb; 50(2):E4. PubMed ID: 33524947
[TBL] [Abstract][Full Text] [Related]
14. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme.
Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH
World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051
[TBL] [Abstract][Full Text] [Related]
15. Targeting Innate Immunity in Glioma Therapy.
Gillard AG; Shin DH; Hampton LA; Lopez-Rivas A; Parthasarathy A; Fueyo J; Gomez-Manzano C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256021
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy.
Feng P; Li Z; Li Y; Zhang Y; Miao X
Front Immunol; 2022; 13():799509. PubMed ID: 35799789
[TBL] [Abstract][Full Text] [Related]
17. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glioblastoma (GBM) molecular classification methods.
Lee E; Yong RL; Paddison P; Zhu J
Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
[TBL] [Abstract][Full Text] [Related]
19. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
20. Impact of age and gender on glioblastoma onset, progression, and management.
Colopi A; Fuda S; Santi S; Onorato A; Cesarini V; Salvati M; Balistreri CR; Dolci S; Guida E
Mech Ageing Dev; 2023 Apr; 211():111801. PubMed ID: 36996926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
